TAGLN
Transgelin
Also known as: DKFZp686P11128, SM22, SMCC, TAGL_HUMAN, TAGLN1, WS3-10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01995
- Gene
- TAGLN
- Ensembl
- ENSG00000149591
- Chromosome
- 11
- Canonical length
- 201 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules,Mitochondria,Cytosol
OverviewNCBI Gene
This gene encodes a shape change and transformation sensitive actin-binding protein which belongs to the calponin family. It is ubiquitously expressed in vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. The encoded protein is thought to be involved in calcium-independent smooth muscle contraction. It acts as a tumor suppressor, and the loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity. The encoded protein has a domain architecture consisting of an N-terminal calponin homology (CH) domain and a C-terminal calponin-like (CLIK) domain. Mice with a knockout of the orthologous gene are viable and fertile but their vascular smooth muscle cells exhibit alterations in the distribution of the actin filament and changes in cytoskeletal organization. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>Q01995|TAGLN
1 MANKGPSYGM SREVQSKIEK KYDEELEERL VEWIIVQCGP DVGRPDRGRL GFQVWLKNGV
61 ILSKLVNSLY PDGSKPVKVP ENPPSMVFKQ MEQVAQFLKA AEDYGVIKTD MFQTVDLFEG
121 KDMAAVQRTL MALGSLAVTK NDGHYRGDPN WFMKKAQEHK REFTESQLQE GKHVIGLQMG
181 SNRGASQAGM TGYGRPRQII SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAGLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 13,588 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 13,588 nTPM
- colon: 8,800 nTPM
- smooth muscle: 6,628 nTPM
- endometrium: 6,524 nTPM
- seminal vesicle: 5,997 nTPM
- urinary bladder: 4,402 nTPM
Single-cell type
- smooth muscle cells: 13,251 nCPM
- vascular smooth muscle cells: 11,546 nCPM
- hepatic stellate cells: 8,895 nCPM
- breast myoepithelial cells: 8,848 nCPM
- decidual stromal cells: 7,514 nCPM
- pericytes: 3,505 nCPM
Immune cell
- non-classical monocyte: 64 nTPM
- intermediate monocyte: 42 nTPM
- naive B-cell: 5.7 nTPM
- memory B-cell: 3.9 nTPM
- myeloid DC: 3.4 nTPM
- classical monocyte: 3 nTPM
Brain region
- choroid plexus: 139 nTPM
- basal ganglia: 80 nTPM
- cerebral cortex: 77 nTPM
- thalamus: 72 nTPM
- medulla oblongata: 65 nTPM
- pons: 49 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAGLN as an antibody target. Whether an autoantibody or antibody against TAGLN could matter depends on whether native TAGLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAGLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TAGLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...